| Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes | Recruiting | P4 | Per Løgstrup Poulsen |
| REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels | Active, not recruiting | P3 | Novo Nordisk A/S |
| Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes NCT06082063 | Recruiting | P3 | Steno Diabetes Center Copenhagen |
| Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy NCT07511543 | Not yet recruiting | P3 | Population Health Research Institute |
| Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome NCT07770282 | Not yet recruiting | P3 | All India Institute of Medical Sciences, Bhubaneswar |
| Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial | Not yet recruiting | P3 | RenJi Hospital |
| Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment | Not yet recruiting | P3 | Wei Hu |
| Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke NCT05630586 | Recruiting | P2 | Aarhus University Hospital |
| Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes NCT07254572 | Recruiting | P4 | National Institute of Cardiology, Warsaw, Poland |
| Focusing on the Menopausal Transition to Improve Mid-Life Women's Health NCT06975111 | Recruiting | P2/P3 | University of Colorado, Denver |
| GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV NCT07221214 | Recruiting | P2 | Vanderbilt University Medical Center |
| Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study) | Enrolling by invitation | P4 | China-Japan Friendship Hospital |
| The POST-ACS Study NCT05322200 | Unknown | P4 | Swansea Bay University Health Board |
| Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies NCT05920889 | Completed | P2 | Chinese University of Hong Kong |
| Semaglutide Treatment On Coronary Progression NCT03985384 | Completed | P4 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center |
| Epicardial Cardiac Fat-CT (EPIC-CT) | Recruiting | P3 | Instituto Mexicano del Seguro Social |
| Effect Of Semaglutide In Coronary Atheroma Plaque NCT05071417 | Unknown | P3 | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León |
| DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies | Not yet recruiting | P4 | Cambridge University Hospitals NHS Foundation Trust |
| Semaglutide and Vascular Regeneration NCT05870462 | Unknown | P4 | Canadian Medical and Surgical Knowledge Translation Research Group |
| Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction | Unknown | P4 | University of Sao Paulo General Hospital |
| Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes NCT05780905 | Recruiting | P4 | University of Washington |
| Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial) NCT07295223 | Recruiting | P3 | Instituto Mexicano del Seguro Social |